注册以创建品种、
财经事件和所关注作者内容的提醒
免费注册 已有账户? 登录
上海复星医药(集团)股份有限公司是一家主要从事医药产品研发、制造与销售的中国公司。该公司的医药产品主要用于新陈代谢及消化系统、心血管系统、中枢神经系统、血液系统、抗肿瘤及抗感染等疾病治疗领域。该公司还从事医疗器械与医学诊断业务以及医疗服务。其产品主要销往中国国内及海外市场。
名称 | 年龄 | 任期 | 标题 |
---|---|---|---|
Guliang Tang | 60 | 2019 | Independent Non-Executive Director |
Qian Ren | 53 | 2018 | Chairman of Supervisory Committee |
Tze Shan Yu | 67 | 2021 | Independent Non-Executive Director |
Yifang Wu | 54 | 2014 | Executive Chairman |
Quandi Wang | 73 | 2021 | Independent Non-Executive Director |
Kexin Wang | 59 | 2011 | Executive Co-Chairman |
Xiaohui Guan | 53 | 2013 | Executive Vice Chairman |
Deyong Wen | 53 | 2020 | Joint President,CEO & Executive Director |
Qiyu Chen | 52 | 2005 | Non-Executive Director |
Bing Chen | 49 | 2023 | Chief Supervisor |
Yimin Guan | 74 | 2007 | Supervisor |
Xiaoliang Xu | 51 | 2019 | Non-Executive Director |
Ling Li | 62 | 2019 | Independent Non-Executive Director |
Donghui Pan | 55 | 2020 | Non Executive Director |
Yuqing Chen | 49 | 2016 | Non-Executive Director |
确定屏蔽%USER_NAME%?
如果屏蔽,您和%USER_NAME%都无法看到相互在Investing.com上发布的信息。
%USER_NAME%已成功添加至屏蔽列表
由于您刚刚取消屏蔽此人,因此必须等待48小时才能重新屏蔽。
您举报该评论的原因为:
谢谢您!
您的举报将会被发送到管理员进行审核